Skip to main content
Journal cover image

18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.

Publication ,  Journal Article
Sheikhbahaei, S; Marcus, C; Subramaniam, RM
Published in: PET Clin
April 2015

There is a growing body of evidence that point to the value of 18F fluoro-deoxyglucose-PET/CT in the management of head and neck cancer (HNC) patients and predicting patient-related outcomes. FDG-PET/CT changes the baseline staging (compared with CT or MR imaging), guides appropriate therapy selection, separates the responders and non-responders for therapy assessment, adds value to clinical assessment in follow-up, and predicts patient survival outcomes. FDG-PET/CT can identify the recurrences in earlier stages and individualize follow-up regimens in HNC patients. This article reviews the value of FDG-PET/CT in management strategy and survival outcome of HNC patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PET Clin

DOI

EISSN

1879-9809

Publication Date

April 2015

Volume

10

Issue

2

Start / End Page

125 / 145

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Retrospective Studies
  • Radiopharmaceuticals
  • Prospective Studies
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Multimodal Imaging
  • Humans
  • Head and Neck Neoplasms
  • Fluorodeoxyglucose F18
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sheikhbahaei, S., Marcus, C., & Subramaniam, R. M. (2015). 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes. PET Clin, 10(2), 125–145. https://doi.org/10.1016/j.cpet.2014.12.001
Sheikhbahaei, Sara, Charles Marcus, and Rathan M. Subramaniam. “18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.PET Clin 10, no. 2 (April 2015): 125–45. https://doi.org/10.1016/j.cpet.2014.12.001.
Sheikhbahaei S, Marcus C, Subramaniam RM. 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes. PET Clin. 2015 Apr;10(2):125–45.
Sheikhbahaei, Sara, et al. “18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.PET Clin, vol. 10, no. 2, Apr. 2015, pp. 125–45. Pubmed, doi:10.1016/j.cpet.2014.12.001.
Sheikhbahaei S, Marcus C, Subramaniam RM. 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes. PET Clin. 2015 Apr;10(2):125–145.
Journal cover image

Published In

PET Clin

DOI

EISSN

1879-9809

Publication Date

April 2015

Volume

10

Issue

2

Start / End Page

125 / 145

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Retrospective Studies
  • Radiopharmaceuticals
  • Prospective Studies
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Multimodal Imaging
  • Humans
  • Head and Neck Neoplasms
  • Fluorodeoxyglucose F18